High-energy Bio-ion Instrument for Coronary Artery Disease

본문 바로가기


Home > Product > High-energy Bio-ion Instrument for Coronary Artery Disease
Product
High-energy Bio-ion Instrument for Coronary Artery Disease
Posting date : Jun 12, 2014
Membership
Free Member Scince Dec 05, 2012
Keyword :
Category
Contact
          0 likes     
Product Detail
Company Info
 
Quick Detail
Place of Origin
HS-CODE
30-
Package & Delivery Lead Time
Detailed Description
Product Name High-energy Bio-ion Instrument for Coronary Artery Disease Product Structure Host Output line Two Physical probe Mechanism of action According to the conductance fundamental equilibrium principle of biological electrophysiological and biological tissue ,High-energy bio-ion instrument for coronary artery disease convert biological ion wave to bio-electric ion and re-integrate the disordered charge for diseased tissue( nerves, bloods, muscles) to restore their normal function when it effects on human body. Especially its high technology not only broke through the difficulties that traditional physical therapy factor is hard to penetrate deeply into human organs and tissues, but also according to the principle of TCM meridian, combined the therapy of acupuncture and moxibustion with the effect of biological ionizing to get excellent physiological and therapeutic effects, and achieve its effect: a. Restore the vasomotion in resistance vessel, relieve wall fibrosis, change the status of vascular stenosis,make the vascular softened and reduce blood pressure. b. Improve microcirculation, increase myocardialinfarction lesion area's blood provide, as well as improve the ischemic injury of myocardial tissue and promote nerve function to activate. c. Relieve myocardial degeneration and the fibrillation of myocardial cell atrophy interstitial, improve coronary atherosclerosis and the status of cardiac hypertrophy. d. Increase the motion of electric charges of nerve cells membrane (inside and outside);improve nerve inflammation edema, enhance the activity of neuronal cell and resurrect nerve function. Clinical characteristics a. Short-term treatment will significantly improve the main symptoms of angina and shortness of breath. b. Long-term treatment will improve the blood supply of coronary, repair the organization of myocardial infarction, delay the progress of disease, and make patients to full recovery. No any treated patient is happened depends on heart surgery or cardiac interventional treatment due to the protracted illness. c. It has been proved by case-by –case that the methods for rescuing patients with acute myocardial infarction are more effective than regular methods. d. Simply physical treatment, safety, no toxic side effect. Adaptation disease a.Initial onset angina pectoris: patients with angina pectoris within one month. b.Stable angina pectoris: patients with angina pectoris more than one month c.Progressive angina pectoris: chest pain that induced by the same degree of fatigue is happen frequency, the severity and duration is also suddently increasing. d.It has been tested and confirmed as the treatment of patients with acute myocardial infarction in acute and convalescent stages. Contraindication a. Patients who had cardiac surgery or interventional cardiology treatment. b. Patients with severe primary disease, including severe hypertension, severe cardiopulmonary dysfunction, severe arrhythmia, as well as the severe primary disease caused by liver, kidney, and hematopoietic system. c. Patients with malignant tumors, bone deformities, internal bleeding, glaucoma and other serious diseases. d. Psychiatric patients e. Pregnant or lactating women f. Children under 12 years old.

ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2024 ECROBOT.COM. All rights reserved.
Top